No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting: Figure 1.
Open accessAbstract
Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection increased dramatically in a large clinical practice setting since 2012. Despite high rates of sexually transmitted infections among PrEP users and reported decreases in condom use in a subset, there were no new HIV infections in this population.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clinical practice guidelines recommend STI screening for persons taking PrEP because increased rates of STI acquisition have been described.
“Clinical practice guidelines recommend STI screening for persons taking PrEP (80) because increased rates of STI acquisition have been described (85–87).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [87]
Cites
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096 · see citing works
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapía, M., Montoya, O., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70847-3 · Cited by 1,204 · see citing works
Risk compensation: the Achilles' heel of innovations in HIV prevention?
Cassell, M. M., Halperin, D. T., Shelton, J. D., & Stanton, D. (2006) · BMJ · doi:10.1136/bmj.332.7541.605 · Cited by 390 · see citing works
Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion.
Bernstein, K. T., Marcus, J. L., Nieri, G., Philip, S. S., & Klausner, J. D. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181c3ef29 · Cited by 360 · see citing works
Self-citationNo Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A., Buchbinder, S., Amico, K. R., McMahan, V., Kallas, E. G., Montoya, O., Pilotto, J. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081997 · Cited by 232 · see citing works
Self-citationHigh Interest in Preexposure Prophylaxis Among Men Who Have Sex With Men at Risk for HIV Infection
Cohen, S. E., Vittinghoff, E., Bacon, O., Doblecki‐Lewis, S., Postle, B. S., Feaster, D. J., Matheson, T., Trainor, N., Blue, R. W., Estrada, Y. A., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000479 · Cited by 190 · see citing works
Solomon, M. M., Mayer, K. H., Glidden, D. V., Liu, A. Y., McMahan, V. M., Guanira, J. V., Chariyalertsak, S., Fernandez, T., Grant, R. M., Bekker, L.-G., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu450 · Cited by 159 · see citing works
Mugwanya, K. K., Donnell, D. J., Celum, C., Thomas, K. K., Ndase, P., Mugo, N., Katabira, E. T., Ngure, K., & Baeten, J. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70226-3 · Cited by 105 · see citing works
Volk, J. E., Marcus, J. L., Phengrasamy, T., & Hare, C. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ129 · Cited by 51 · see citing works
Self-citationPre-exposure prophylaxis for sexually-acquired HIV risk management: a review
Tan, D. H. S., Senn, H., Sharma, M., & Wilton, J. (2015) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s50025 · Cited by 47 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 2,759 · see citing works
Molina, J.-M., Charreau, I., Spire, B., Cotte, L., Chas, J., Capitant, C., Tremblay, C., Rojas-Castro, D., Cua, E., Pasquet, A., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30089-9 · Cited by 472 · see citing works
Molina, J.-M., Charreau, I., Chidiac, C., Pialoux, G., Cua, E., Delaugerre, C., Capitant, C., Rojas-Castro, D., Fonsart, J., Bercot, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30725-9 · Cited by 449 · see citing works
Traeger, M. W., Schroeder, S. E., Wright, E. J., Hellard, M. E., Cornelisse, V. J., Doyle, J. S., & Stoové, M. A. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy182 · Cited by 447 · see citing works
Mayer, K. H., Molina, J.-M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., DeJesus, E., Jessen, H., Grant, R. M., Ruane, P. J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31065-5 · Cited by 428 · see citing works
Self-citationPrEP stigma: implicit and explicit drivers of disparity
Golub, S. A. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0385-0 · Cited by 383 · see citing works
Jenness, S. M., Weiss, K. M., Goodreau, S. M., Gift, T., Chesson, H., Hoover, K. W., Smith, D. K., Liu, A. Y., Sullivan, P. S., & Rosenberg, E. S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix439 · Cited by 224 · see citing works
Ong, J. J., Baggaley, R. C., Wi, T. E., Tucker, J. D., Fu, H., Smith, M. K., Rafael, S., Anglade, V., Falconer, J., Ofori-Asenso, R., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17134 · Cited by 173 · see citing works
Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting.
Montaño, M. A., Dombrowski, J. C., Dasgupta, S., Golden, M. R., Duerr, A., Manhart, L. E., Barbee, L. A., & Khosropour, C. M. (2019) · AIDS and Behavior · doi:10.1007/s10461-018-2252-9 · Cited by 155 · see citing works
Confronting Rising STIs in the Era of PrEP and Treatment as Prevention
Ramchandani, M. S., & Golden, M. R. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00446-5 · Cited by 84 · see citing works
Oldenburg, C. E., Nunn, A. S., Montgomery, M., Almonte, A., Mena, L., Patel, R. R., Mayer, K. H., & Chan, P. A. (2018) · AIDS and Behavior · doi:10.1007/s10461-017-1701-1 · Cited by 76 · see citing works
Tang, E. C., Vittinghoff, E., Philip, S. S., Doblecki-Lewis, S., Bacon, O., Chege, W., Coleman, M. E., Elion, R., Buchbinder, S., Kolber, M. A., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002522 · Cited by 31 · see citing works
- Authors
- Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B.
- Affiliations
- Kaiser Permanente San Francisco Medical Center (US)
- Kaiser Permanente (US)
- Corresponding author
- Volk, Jonathan E.
- ORCID
- Marcus, Julia L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-09-01
- Volume
- 61
- Issue
- 10
- Pages
- 1601-1603
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4809999
- OpenAlex
- W1898465070
- Cited by
- 489
- References
- 10
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 22 · 2023: 24 · 2022: 28 · 2021: 33 · 2020: 40 · 2019: 63 · 2018: 81 · 2017: 81 · 2016: 73 · 2015: 12
- FWCI
- 63.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kaiser Permanente
- National Institute of Mental Health (T32MH019105, P30MH062246)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- HIV pre-exposure prophylaxis, HIV prevention, HIV incidence, PrEP users, sexually transmitted infections, condom use
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, HIV Infections, Homosexuality, Male, Chemoprevention, Young Adult, Pre-Exposure Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review